| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Additional local consolidative therapy has survival benefit over EGFR tyrosine kinase inhibitors alone in bone oligometastatic lung adenocarcinoma patients
|
Hu, Fang
|
|
|
135 |
C |
p. 138-144
|
artikel
|
| 2 |
Airflow limitation and survival after surgery for non-small cell lung cancer: Results from a systematic review and lung cancer screening trial (NLST-ACRIN sub-study)
|
Hopkins, R.J.
|
|
|
135 |
C |
p. 80-87
|
artikel
|
| 3 |
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma
|
Morra, Francesco
|
|
|
135 |
C |
p. 56-65
|
artikel
|
| 4 |
A phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small-cell lung cancer (KTORG1402)
|
Yokoyama, Toshihide
|
|
|
135 |
C |
p. 175-180
|
artikel
|
| 5 |
A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer
|
Guo, Jia
|
|
|
135 |
C |
p. 47-55
|
artikel
|
| 6 |
Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment
|
Messaritakis, Ippokratis
|
|
|
135 |
C |
p. 33-39
|
artikel
|
| 7 |
Circulating miR-30b and miR-30c predict erlotinib response in EGFR-mutated non-small cell lung cancer patients
|
Hojbjerg, Johanne Andersen
|
|
|
135 |
C |
p. 92-96
|
artikel
|
| 8 |
Clinical significance of ROS1 5’ deletions in non-small cell lung cancer
|
Capizzi, Elisa
|
|
|
135 |
C |
p. 88-91
|
artikel
|
| 9 |
Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with adenocarcinoma of the lung
|
Wang, Shuhang
|
|
|
135 |
C |
p. 116-122
|
artikel
|
| 10 |
Contents
|
|
|
|
135 |
C |
p. v-vii
|
artikel
|
| 11 |
Corrigendum to “Treatment and outcome of 432 patients with extensive-stage small cell lung cancer in first, second and third line – Results from the prospective German TLK cohort study” [Lung Cancer 130 (2019) (April) 216–225]
|
Steffens, Claus-Christoph
|
|
|
135 |
C |
p. 236
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
135 |
C |
p. iii
|
artikel
|
| 13 |
Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis
|
Griesinger, Frank
|
|
|
135 |
C |
p. 196-204
|
artikel
|
| 14 |
Erratum to “Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence” [Lung Cancer 132 (June) (2019) 141–149]
|
Grøndahl, V.
|
|
|
135 |
C |
p. 235
|
artikel
|
| 15 |
Erratum to “Vasculature surrounding a nodule: A novel lung cancer biomarker” [Lung Cancer 114 (December) (2017) 38–43]
|
Wang, Xiaohua
|
|
|
135 |
C |
p. 234
|
artikel
|
| 16 |
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy10 enough?
|
Abel, Stephen
|
|
|
135 |
C |
p. 169-174
|
artikel
|
| 17 |
Expression of delta-like protein 3 is reproducibly present in a subset of small cell lung carcinomas and pulmonary carcinoid tumors
|
Xie, Hao
|
|
|
135 |
C |
p. 73-79
|
artikel
|
| 18 |
Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review
|
Konstantina, Thomopoulou
|
|
|
135 |
C |
p. 29-32
|
artikel
|
| 19 |
Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer
|
Zhang, Li
|
|
|
135 |
C |
p. 130-137
|
artikel
|
| 20 |
I love my dog
|
Muller, M.
|
|
|
135 |
C |
p. 228-229
|
artikel
|
| 21 |
Impact of health care organization on surgical lung cancer care
|
Heineman, D.J.
|
|
|
135 |
C |
p. 181-187
|
artikel
|
| 22 |
Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
|
Noor, Zorawar S.
|
|
|
135 |
C |
p. 104-109
|
artikel
|
| 23 |
Lung cancers associated with cystic airspaces: CT features and pathologic correlation
|
Shen, Yingran
|
|
|
135 |
C |
p. 110-115
|
artikel
|
| 24 |
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)
|
Isla, Dolores
|
|
|
135 |
C |
p. 161-168
|
artikel
|
| 25 |
Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation
|
Bodor, J. Nicholas
|
|
|
135 |
C |
p. 16-20
|
artikel
|
| 26 |
Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis
|
Fraser, Ian
|
|
|
135 |
C |
p. 97-103
|
artikel
|
| 27 |
Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer
|
Udagawa, Hibiki
|
|
|
135 |
C |
p. 145-150
|
artikel
|
| 28 |
Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features
|
Khorrami, Mohammadhadi
|
|
|
135 |
C |
p. 1-9
|
artikel
|
| 29 |
Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression
|
Denisov, Evgeny V.
|
|
|
135 |
C |
p. 21-28
|
artikel
|
| 30 |
Residential radon, genetic polymorphisms in DNA damage and repair-related
|
Lorenzo-González, María
|
|
|
135 |
C |
p. 10-15
|
artikel
|
| 31 |
Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1–positive advanced non–small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies
|
Nosaki, Kaname
|
|
|
135 |
C |
p. 188-195
|
artikel
|
| 32 |
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial
|
Kim, Dong-Wan
|
|
|
135 |
C |
p. 66-72
|
artikel
|
| 33 |
Searching for selected VOCs in human breath samples as potential markers of lung cancer
|
Rudnicka, Joanna
|
|
|
135 |
C |
p. 123-129
|
artikel
|
| 34 |
Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis
|
Cadham, Christopher J.
|
|
|
135 |
C |
p. 205-216
|
artikel
|
| 35 |
Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer
|
Alcaraz, Jordi
|
|
|
135 |
C |
p. 151-160
|
artikel
|
| 36 |
Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC
|
Ryan, Sarah-Louise
|
|
|
135 |
C |
p. 217-227
|
artikel
|
| 37 |
Toward improving prognosis prediction in patients undergoing small lung adenocarcinoma resection: Radiological and pathological assessment of diversity and intratumor heterogeneity
|
Koezuka, Satoshi
|
|
|
135 |
C |
p. 40-46
|
artikel
|
| 38 |
Trained dogs can identify malignant solitary pulmonary nodules in exhaled gas
|
Guirao, A.
|
|
|
135 |
C |
p. 230-233
|
artikel
|
Tijdschrift beschrijving